Requiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or the designee of the medical director of Medicaid managed care organizations for the purpose of complying with the Corrective Managed Care Program of the Maryland Medicaid Pharmacy Program or the standards developed by the Maryland Medicaid Opioid Drug Utilization Review Workgroup.
Bill File Type: Regular
Effective Date(s): October 1, 2019
( 21-2A-06 )
Last Updated: 2/3/2020 2:33 PM